Clik here to view.
NeuroVia Initiates Phase 1/2 Trial of NV1205 for Treating Childhood Cerebral...
SAN FRANCISCO NeuroVia, Inc., a biopharmaceutical company focused on developing innovative therapies for rare, genetic neurological diseases, today announced the initiation of a Phase 1/2 clinical...
View ArticleClik here to view.
Genome Editing Biotech EdiGene Names Dong Wei, Ph.D., MBA as its Chief...
BEIJING & CAMBRIDGE, Mass. EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery,...
View ArticleClik here to view.
Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class...
REDWOOD CITY, Calif. & OSAKA, Japan Ambys Medicines, a biotechnology company focused on the discovery and development of transformative therapies for people with serious liver disease, and...
View ArticleClik here to view.
Genome Editing Biotech Company EdiGene Raises $15 Million in Series pre-B...
BEIJING & CAMBRIDGE, Mass. EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery,...
View ArticleClik here to view.
Vertex Receives a Positive PBAC Recommendation for Reimbursement of ORKAMBI®...
LONDON Vertex Pharmaceuticals (Europe) Limited announces that it has received the Pharmaceutical Benefits Advisory Committee’s (PBAC) recommendation for ORKAMBI® (lumacaftor/ivacaftor) to be listed...
View ArticleClik here to view.
Patient-Driven Gene Therapy Company ReflectionBio Receives Orphan Drug...
HONG KONG & NEW YORK Reflection Biotechnologies Limited (“ReflectionBio”), a gene therapy company committed to the research and development of life-changing treatments for rare diseases, today...
View ArticleClik here to view.
Geneious Desktop Software to Be Renamed to Geneious Prime
AUCKLAND, New Zealand Biomatters today announces that Geneious, its world-leading desktop suite of molecular biology and sequence analysis tools, will be renamed to Geneious Prime later this year....
View ArticleClik here to view.
Illumina的MiSeq™Dx系统在中国获得核准
圣迭戈 (美国商业资讯) — Illumina, Inc. (NASDAQ:ILMN)今天宣布，其MiSeq™Dx测序系统获得中国国家药品监督管理局(CNDA)核准。这是Illumina首款获得CNDA核准的下一代测序(NGS)系统。获得该核准后，Illumina现在可以向全中国的医院和其他医疗机构推广和销售MiSeqDx测序系统，用于体外诊断(IVD)检测。...
View ArticleClik here to view.
Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
SAN FRANCISCO & BOSTON Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 leading venture capital firms. The funds will support the...
View ArticleClik here to view.
Nebula Genomics从领先的技术和生物技术风投公司筹集430万美元种子经费
旧金山和波士顿 (美国商业资讯) — Nebula Genomics今天宣布已从10家领先的风投公司筹集430万美元种子经费。该经费将支持公司的使命，即创建一个值得信赖的、安全的、去中央化基因组数据市场，引领个人基因组测序的纪元。公司同时已与领先的全基因组测序和解读公司Veritas Genetics铸就伙伴关系，后者将把Nebula市场与Veritas的Arvados开源软件平台联接起来。...
View ArticleClik here to view.
ネビュラ・ゲノミクスが大手テクノロジー／バイオテクノロジーベンチャーキャピタルからシードファイナンスで430万ドルを調達
サンフランシスコ & ボストン （ビジネスワイヤ） —...
View ArticleClik here to view.
Meet with Selexis Scientific and Business Leaders at Several Upcoming...
GENEVA Selexis SA, a pioneering life sciences company and a global leader in mammalian cell line generation technology, announced today that several of its scientific and business leaders will be...
View ArticleClik here to view.
2018 Taiwan healthcare+ Expo: 亚洲医疗科技创新论坛-Med x Tech Summit Asia
台北, 台湾 国际级医疗水准与资通讯产业实力，台湾有机会引领医疗科技发展方向，全球首个以「医疗x科技」为主题台湾医疗科技展Taiwan Healthcare+ Expo，即将在11/29～12/02在南港展览馆登场！展会同时举办2018亚洲医疗科技创新论坛Med x Tech Summit...
View ArticleClik here to view.
MEDTEX: Foresee the Next Wave of Healthcare Revolution
TAIPEI, Taiwan Taiwan, with high quality medical service and world’s top IT industry, has becoming one of the leaders in global healthcare technology and provider. On November 29 – 30, MEDTEX will...
View ArticleClik here to view.
MEDTEX:ヘルスケア革命の次なる波を予見する
台湾・台北 （ビジネスワイヤ） — 質の高い医療サービスと世界トップのIT産業を擁する台湾は、世界的医療技術のリーダーの一角を占め、こうした技術の提供国となりました。11月29日～30日に開催されるMEDTEXでは、重要な3つの動向、すなわちインテリジェントヘルスケア、次世代のバイオ医薬品、バイオイノベーションに着眼します。MEDTEXには世界的に有名な専門家が30人以上参加します。...
View ArticleClik here to view.
Konica Minolta Launches Dedicated Precision Medicine Business in Japan
TOKYO Konica Minolta, Inc. (“Konica Minolta”) (TOKYO: 4902) (ISIN: JP3300600008) today announced the launch of Konica Minolta Precision Medicine Japan, Inc. (“KMPMJ”) which will start operations on...
View ArticleClik here to view.
PerkinElmer and DBT- ICT Inaugurate “explorer™ G3 Project”– an Advanced...
MUMBAI, India PerkinElmer, Inc., a global leader committed to innovating for a healthier world, collaborated with Institute of Chemical Technology (ICT) to open “explorerTM G3 Project,” an advanced...
View ArticleClik here to view.
Alnylam Announces Submission of New Drug Application in Japan for ONPATTRO™...
CAMBRIDGE, Mass. Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it has submitted a New Drug Application (NDA) to Japan’s Pharmaceuticals...
View ArticleClik here to view.
Axcelead Drug Discovery Partners とERS Genomics、CRISPR /...
藤沢市 （ビジネスワイヤ）– Axcelead Drug Discovery Partners 株式会社社（代表取締役社長：池浦義典、本社：神奈川県藤沢市、以下「アクセリード」）とERS Genomics Limited（代表取締役社長：エリック・ローズ、本社：アイルランド ダブリン、以下「ERS」）は、ERSが管理するCRISPR /...
View ArticleClik here to view.
Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9...
FUJISAWA, Japan & DUBLIN Axcelead Drug Discovery Partners, Inc.(hereinafter referred to as “Axcelead”) and ERS Genomics Limited (hereinafter referred to as “ERS Genomics”) announced today a...
View Article